Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | - |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2.02 | 0.96 |
NAV | ₹10.60 | ₹74.15 |
Fund Started | 06 May 2025 | 29 Jan 2005 |
Fund Size | ₹2307.94 Cr | ₹107.04 Cr |
Exit Load | Exit load of 1%, if redeemed within 12 months.
| Exit load of 0.25% if redeemed within 1 month |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | - | 6.54% |
3 Year | - | 19.27% |
5 Year | - | 21.15% |
1 Year
3 Year
5 Year
Equity | 92.88% | 97.91% |
Cash | 5.39% | 2.08% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Infosys Ltd. | 7.55% |
Sun Pharmaceutical Industries Ltd. | 6.40% |
SBI Life Insurance Company Ltd. | 3.73% |
Alkem Laboratories Ltd. | 3.52% |
Tata Consultancy Services Ltd. | 3.37% |
Hindustan Unilever Ltd. | 3.13% |
HDFC Bank Ltd. | 3.06% |
ITC Ltd. | 2.80% |
Astrazeneca Pharma India Ltd. | 2.30% |
Info Edge (India) Ltd. | 2.19% |
Name | Assets |
|---|---|
HDFC Bank Ltd. | 7.66% |
ICICI Bank Ltd. | 6.28% |
Reliance Industries Ltd. | 5.90% |
Larsen & Toubro Ltd. | 5.08% |
State Bank of India | 4.64% |
Bharti Airtel Ltd. | 4.22% |
Infosys Ltd. | 4.15% |
Bharat Electronics Ltd. | 3.78% |
Mahindra & Mahindra Ltd. | 3.58% |
Bajaj Finance Ltd. | 3.12% |
Name | Ihab Dalwai | Akshay Sharma |
Start Date | 06 May 2025 | 01 Dec 2022 |
Name
Start Date
Description | The scheme seeks to generate long-term capital appreciation by investing in Equity & Equity related instruments of companies identified based on the Quality Factor. | The Scheme seeks to generate capital appreciation through investment in equity and equity related instruments. The Scheme will seek to generate capital appreciation by investing in an active portfolio of stocks selected on the basis of a Quant model. |
Launch Date | 06 May 2025 | 29 Jan 2005 |
Description
Launch Date